Human chorionic gonadotropin value and its change prior to methotrexate treatment can predict the prognosis in ectopic tubal pregnancies.

Koichi WatanabeYoshitsugu ChigusaEiji KondohHaruta MogamiAkihito HorieTsukasa BabaMasaki Mandai

Published in: Reproductive medicine and biology (2018)

Pretreatment HCG change is a significant predictor of therapeutic success of MTX treatment, and the treatment period may be predicted from initial HCG levels.

Keyphrases

endothelial cells
combination therapy
replacement therapy